Universal Health Realty Income Trust financials
$38.01−2.01%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $25.0M | $24.5M | $28.5M | $24.0M | $24.9M | $24.5M | $28.7M | $23.1M | $23.4M | $25.1M | $28.4M | $22.9M |
| Gross profit | $25.0M | $24.5M | $28.5M | $24.0M | $24.9M | $24.5M | $28.7M | $23.1M | $23.4M | $25.1M | $28.4M | $22.9M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $9.2M | $9.0M | $12.5M | $7.0M | $8.8M | $9.0M | $13.3M | $7.1M | $8.2M | $9.5M | $12.3M | $6.7M |
| Net income | $5.9M | $5.0M | $4.3M | $4.0M | $4.5M | $4.8M | $4.7M | $4.0M | $5.3M | $5.3M | $3.6M | $3.9M |
| Net margin | 23.6% | 20.5% | 15.2% | 16.8% | 18.1% | 19.5% | 16.2% | 17.3% | 22.6% | 21.1% | 12.6% | 16.9% |
| Diluted EPS | $0.43 | $0.36 | $0.31 | $0.29 | $0.32 | $0.34 | $0.34 | $0.29 | $0.38 | $0.38 | $0.26 | $0.28 |
| EBITDA | $16.2M | $15.9M | $19.7M | $14.9M | $15.8M | $15.9M | $20.1M | $14.1M | $15.1M | $16.2M | $12.3M | $13.6M |
| Operating cash flow | $12.4M | $11.9M | $13.6M | $10.2M | $13.7M | $11.6M | $13.2M | $9.9M | $12.1M | $11.7M | $7.1M | -$2.1M |
| Free cash flow | $12.4M | $11.9M | $13.6M | $10.2M | $13.7M | $11.6M | $13.2M | $9.9M | $12.1M | $11.7M | $7.1M | -$9.7M |
| Diluted shares | 13.9M | 13.9M | 13.9M | 13.9M | 13.9M | 13.9M | 13.9M | 13.8M | 13.8M | 13.8M | 13.8M | 13.8M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.8M | $7.1M | $6.7M | $6.9M | $6.6M | $7.0M |
| Short-term investments | $20.0M | $20.4M | $20.1M | $20.8M | $20.9M | $14.4M |
| Total debt | $384.6M | $377.8M | $375.5M | $376.5M | $374.4M | $369.2M |
| Total assets | $567.1M | $563.8M | $564.9M | $568.0M | $573.0M | $573.5M |
| Total liabilities | $423.2M | $416.0M | $412.5M | $409.5M | $407.9M | $401.3M |
| Shareholders' equity | $143.9M | $147.8M | $152.4M | $158.6M | $165.2M | $172.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology